Pathogenesis of postoperative adhesion formation

British Journal of Surgery

Volumn 98, Issue 11, 2011, Pages 1503-1516

  Hellebrekers, B W J ^a   Kooistra, T ^b  

^a HAGA HOSPITAL   (Netherlands)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR;

ANIMAL; ASCITES FLUID; BIOPSY; BLOOD; BLOOD CLOTTING; CHEMISTRY; FIBRINOLYSIS; HUMAN; METABOLISM; PATHOLOGY; PERITONEUM; PERITONITIS; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; RAT; REVIEW; TISSUE ADHESION;

ANIMALS; ASCITIC FLUID; BIOPSY; BLOOD COAGULATION; FIBRINOLYSIS; HUMANS; PERITONEUM; PERITONITIS; PLASMINOGEN ACTIVATORS; PLASMINOGEN INACTIVATORS; POSTOPERATIVE COMPLICATIONS; RATS; TISSUE ADHESIONS;

EID: 80053564370     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7657     Document Type: Review

References (116)

1. Ellis H, Moran BJ, Thompson JN, Parker MC, Wilson MS, Menzies D, et al., Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet 1999; 353: 1476-1480. (Pubitemid 29204365)
2. Nieuwenhuijzen M, Reijen MM, Kuijpers JH, van Goor H,. Small bowel obstruction after total or subtotal colectomy: a 10-year retrospective review. Br J Surg 1998; 85: 1242-1245. (Pubitemid 28430427)
3. Trimbos-Kemper TC, Trimbos JB, van Hall EV,. Adhesion formation after tubal surgery: results of the eight day laparoscopy in 188 patients. Fertil Steril 1985; 43: 395-400. (Pubitemid 15111126)
4. Cates W, Farley TM, Rowe PJ,. Worldwide patterns of infertility: is Africa different? Lancet 1985; 2: 596-598. (Pubitemid 15232289)
5. Parker MC, Ellis H, Moran BJ, Thompson JN, Wilson MS, Menzies D, et al., Postoperative adhesions: ten-year follow-up of 12 584 patients undergoing lower abdominal surgery. Dis Colon Rectum 2001; 44: 822-829.
6. Lower AM, Hawthorn RJ, Ellis H, O'Brien F, Buchan S, Crowe AM,. The impact of adhesions on hospital readmissions over ten years after 8849 open gynaecological operations: an assessment from the Surgical and Clinical Adhesions Research Study. BJOG 2000; 107: 855-862. (Pubitemid 30417341)
7. Thompson JN, Paterson-Brown S, Harbourne T, Whawell SA, Kalodiki E, Dudley HA,. Reduced human peritoneal plasminogen activating activity: possible mechanism of adhesion formation. Br J Surg 1989; 76: 382-384. (Pubitemid 19111786)
8. Vipond MN, Whawell SA, Thompson JN, Dudley HA,. Peritoneal fibrinolytic activity and intra-abdominal adhesions. Lancet 1990; 335: 1120-1122. (Pubitemid 20159427)
9. Scott-Coombes DM, Whawell SA, Vipond MN, Thompson JN,. Elective surgery inhibits intraperitoneal fibrinolysis. Br J Surg 1994; 81: 770.
10. di Zerega GS,. The cause and prevention of postsurgical adhesions: a contemporary update. Prog Clin Biol Res 1993; 381: 1-18.
11. Gardner E,. Abdominal viscera and peritoneum. In Anatomy: a Regional Study of Human Structure (3rd edn), Gardner E, Gray DJ, O'Rahilly R, (eds). WB Saunders: Philadelphia, 1969; 387-395.
12. Bloom W,. Blood cell formation and destruction. In A Textbook of Histology (9th edn), Bloom W, Fawcett DW, (eds). WB Saunders: Philadelphia, 1978; 186-187.
13. Flessner MF,. Peritoneal transport physiology: insights from basic research. J Am Soc Nephrol 1991; 2: 122-135.
14. Mutsaers SE, Wilkosz S,. Structure and function of mesothelial cells. Cancer Treat Res 2007; 134: 1-19.
15. diZerega GS,. Biochemical events in peritoneal tissue repair. Eur J Surg 1997; (577): 10-16.
16. diZerega GS, Campeau JD,. Peritoneal repair and post-surgical adhesion formation. Hum Reprod Update 2001; 7: 547-555. (Pubitemid 33069613)
17. Holtz G,. Prevention and management of peritoneal adhesions. Fertil Steril 1984; 41: 497-507.
18. Alpay Z, Saed GM, Diamond MP,. Postoperative adhesions: from formation to prevention. Semin Reprod Med 2008; 26: 313-321.
19. Collen D, Lijnen HR,. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy. Thromb Haemost 1995; 74: 167-171.
20. Collen D,. On the regulation and control of fibrinolysis. Thromb Haemost 1980; 43: 77-89.
21. Kluft C, Los N,. Demonstration of two forms of α2-antiplasmin in plasma by modified crossed immunelectrophoresis. Thromb Res 1981; 21: 65-71. (Pubitemid 11147786)
22. Moroi M, Aoki N,. Isolation and characterization of alpha-2-plasmin inhibitor from human plasma: a novel proteinase inhibitor which inhibits activator-induced clot lysis. J Biol Chem 1976; 251: 5956-5965.
23. Kimura S, Aoki N,. Cross-linking site in fibrinogen for α-2-plasmin inhibitor. J Biol Chem 1986; 261: 15 591-15 595.
24. Hoylaerts M, Rijken DC, Lijnen HR, Collen D,. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 1982; 257: 2912-2919. (Pubitemid 12118804)
25. Williams JRB,. The fibrinolytic activity of urine. Br J Exp Biol 1951; 32: 530-537.
26. Hekman CM, Loskutoff DJ,. Fibrinolytic pathways and the endothelium. Semin Thromb Hemost 1987; 13: 514-527. (Pubitemid 18007754)
27. Saksela O, Hovi T, Vaheri A,. Urokinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages. J Cell Physiol 1985; 122: 125-132. (Pubitemid 15177237)
28. Lu HR, Wu Z, Pauwels P, Lijnen HR, Collen D,. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog. J Am Coll Cardiol 1992; 19: 1350-1359.
29. Runge MS, Quertermous T, Haber E,. Plasminogen activators. The old and the new. Circulation 1989; 79: 217-224. (Pubitemid 19055491)
30. Blasi F,. Urokinase and urokinase receptor: a paracrine/autocrine system regulating cell migration and invasiveness. BioEssays 1993; 15: 105-111.
31. Vassalli JD, Pepper MS,. Tumour biology. Membrane proteases in focus. Nature 1994; 370: 14-15. (Pubitemid 24216941)
32. Sprengers ED, Kluft C,. Plasminogen activator inhibitors. Blood 1987; 69: 381-387. (Pubitemid 17022002)
33. Kruithof EK, Tran-Thang C, Ransijn A, Bachmann F,. Demonstration of a fast acting inhibitor of plasminogen activators in human plasma. Blood 1984; 64: 907-913. (Pubitemid 14003614)
34. van Mourik JA, Lawrence DA, Loskutoff DJ,. Purification of an inhibitor of plasminogen activator (antiactivator) synthesised by endothelial cells. J Biol Chem 1984; 259: 14 914-14 921.
35. Colucci M, Paramo JA, Collen D,. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest 1985; 75: 818-824. (Pubitemid 15111003)
36. Nachman RL, Hajjar KA, Silverstein RL, Dinarello CA,. Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med 1986; 163: 1595-1600. (Pubitemid 16043476)
37. van Hinsbergh VW, Kooistra T, van den Berg EA, Princen HM, Fiers W, Emeis JJ,. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood 1988; 72: 1467-1473. (Pubitemid 18268620)
38. de Boer JP, Abbink JJ, Brouwer MC, Meijer C, Roem D, Voorn GP, et al., PAI-1 synthesis in the human hepatoma cell line HepG2 is increased by cytokines-evidence that the liver contributes to acute phase behaviour of PAI-1. Thromb Haemost 1991; 65: 181-185.
39. Travis JJ, Salvesen GS,. Human plasma proteinase inhibitors. Annu Rev Biochem 1983; 254: 655-709. (Pubitemid 13030691)
40. Åstedt B, Hägerstrand I, Lecander I,. Cellular localisation in placenta of placental type plasminogen activator inhibitor. Thromb Haemost 1986; 56: 63-65. (Pubitemid 16015918)
41. Kopitar M, Rozman B, Babnik J, Turk V, Mullins DE, Wun TC,. Human leucocyte urokinase inhibitor-purification, characterization and comparative studies against different plasminogen activators. Thromb Haemost 1985; 54: 750-755. (Pubitemid 16179910)
42. Hartwell SW,. Fibrous healing in human surgical wounds. In The Mechanics of Healing in Human Wounds, Hartwell SE, (ed.). Thomas: Springfield, 1955; 109.
43. Von Benzer H, Blumel G, Piza F,. [On relations between fibrinolysis and interperitoneal adhesions.] Wien Klin Wochenschr 1963; 75: 881-883.
44. Myhre-Jensen O, Larsen SB, Astrup T,. Fibrinolytic activity in serosal and synovial membranes. Rats, guinea pigs, and rabbits. Arch Pathol 1969; 88: 623-630.
45. Gervin AS, Puckett CL, Silver D,. Serosal hypofibrinolysis, a cause of postoperative adhesions. Am J Surg 1973; 125: 80-88.
46. Porter JM, McGregor GH Jr, Mullen DC, Silver D,. Fibrinolytic activity of mesothelial surfaces. Surg Forum 1969; 20: 80-82.
47. Buckman RF, Woods M, Sargent L, Gervin AS,. A unifying pathogenetic mechanism in the etiology of intraperitoneal adhesions. J Surg Res 1976; 20: 1-5.
48. Buckman RF Jr, Buckman PD, Hufnagel HV, Gervin AS,. A physiologic basis for the adhesion-free healing of deperitonealized surfaces. J Surg Res 1976; 21: 67-76.
49. Hau T, Payne WD, Simmons RL,. Fibrinolytic activity of the peritoneum during experimental peritonitis. Surg Gynecol Obstet 1979; 148: 415-418. (Pubitemid 9137839)
50. Raftery AT,. Effect of peritoneal trauma on peritoneal fibrinolytic activity and intraperitoneal adhesion formation. An experimental study in the rat. Eur Surg Res 1981; 13: 397-401. (Pubitemid 12163166)
51. Ryan GB, Grobéty J, Majno G,. Mesothelial injury and recovery. Am J Pathol 1973; 71: 93-112.
52. Molinas CR, Elkelani O, Campo R, Luttun A, Carmeliet P, Koninckx PR,. Role of the plasminogen system in basal adhesion formation and carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice. Fertil Steril 2003; 80: 184-192. (Pubitemid 36808876)
53. Vipond MN, Whawell SA, Thompson JN, Dudley AF,. Effect of experimental peritonitis and ischaemia on peritoneal fibrinolytic activity. Eur J Surg 1994; 160: 471-477. (Pubitemid 24306979)
54. Bakkum EA, Emeis JJ, Dalmeijer RAJ, van Blitterswijk CA, Trimbos JB, Trimbos-Kemper TC,. Long-term analysis of peritoneal plasminogen activator activity and adhesion formation after surgical trauma in the rat model. Fertil Steril 1996; 66: 1018-1022. (Pubitemid 26423690)
55. Reijnen MM, Holmdahl L, Kooistra T, Falk P, Hendriks T, van Goor H,. Time course of peritoneal tissue plasminogen activator after experimental colonic surgery: effect of hyaluronan-based antiadhesive agents and bacterial peritonitis. Br J Surg 2002; 89: 103-109. (Pubitemid 34031317)
56. van Goor H, de Graaf JS, Grond J, Sluiter WJ, van der Meer J, Bom VJ, et al., Fibrinolytic activity in the abdominal cavity of rats with faecal peritonitis. Br J Surg 1994; 81: 1046-1049. (Pubitemid 24230110)
57. Bouckaert PX, Land JA, Brommer EJP, Emeis JJ, Evers JLH,. The impact of peritoneal trauma on intra-abdominal fibrinolytic activity, adhesion formation and early embryonic development in a rabbit longitudinal model. Hum Reprod 1990; 5: 237-241. (Pubitemid 20253434)
58. Hellebrekers BW, Trimbos-Kemper GC, Bakkum EA, Trimbos JB, Declerck P, Kooistra T, et al., Short-term effect of surgical trauma on rat peritoneal fibrinolytic activity and its role in adhesion formation. Thromb Haemost 2000; 84: 876-881.
59. Whawell SA, Vipond MN, Scott-Coombes DM, Thompson JN,. Plasminogen activator inhibitor 2 reduces peritoneal fibrinolytic activity in inflammation. Br J Surg 1993; 80: 107-109. (Pubitemid 23071492)
60. Holmdahl L, Eriksson E, al-Jabreen M, Risberg B,. Fibrinolysis in human peritoneum during operation. Surgery 1996; 119: 701-705. (Pubitemid 26182458)
61. Ince A, Eroglu A, Tarhan O, Bülbül M,. Peritoneal fibrinolytic activity in peritonitis. Am J Surg 2002; 183: 67-69. (Pubitemid 34178609)
62. Dörr PJ, Brommer EJP, Dooijewaard G, Vemer HM,. Peritoneal fluid and plasma fibrinolytic activity in women with pelvic inflammatory disease. Thromb Haemost 1992; 68: 102-105.
63. van Goor, Bom VJ, van der Meer J, Sluiter WJ, Bleichrodt RP,. Coagulation and fibrinolytic responses of human peritoneal fluid and plasma to bacterial peritonitis. Br J Surg 1996; 83: 1133-1135. (Pubitemid 26291231)
64. Edelstam G, Lecander I, Larsson B,. Fibrinolysis in the peritoneal fluid during adhesions, endometriosis and ongoing pelvic inflammatory disease. Inflammation 1998; 22: 341-351. (Pubitemid 28376851)
65. Scott-Coombes DM, Whawell SA, Thompson JN,. The operative peritoneal fibrinolytic response to abdominal operation. Eur J Surg 1995; 161: 395-399.
66. Ivarsson ML, Bergström M, Eriksson E, Risberg B, Holmdahl L,. Tissue markers as predictors of postoperative adhesions. Br J Surg 1998; 85: 1549-1554. (Pubitemid 28502590)
67. Bergström M, Ivarsson ML, Holmdahl L,. Peritoneal response to pneumoperitoneum and laparoscopic surgery. Br J Surg 2002; 89: 1465-1469.
68. Neudecker J, Junghans T, Ziemer S, Raue W, Schwenk W,. Effect of laparoscopic and conventional colorectal resection on peritoneal fibrinolytic capacity: a prospective randomized clinical trial. Int J Colorectal Dis 2002; 17: 426-429. (Pubitemid 36075792)
69. Brokelman WJ, Holmdahl L, Bergström M, Falk P, Klinkenbijl JH, Reijnen MM,. Peritoneal fibrinolytic response to various aspects of laparoscopic surgery: a randomized trial. J Surg Res 2006; 136: 309-313. (Pubitemid 44737854)
70. Brokelman WJ, Holmdahl L, Janssen IM, Falk P, Bergström M, Klinkenbijl JH, et al., Decreased peritoneal tissue plasminogen activator during prolonged laparoscopic surgery. J Surg Res 2009; 151: 89-93.
71. Holmdahl L,. The role of fibrinolysis in adhesion formation. Eur J Surg 1997; 577: 24-31. (Pubitemid 27115967)
72. Scott-Coombes DM, Whawell SA, Vipond MN, Thompson JN,. Human intraperitoneal fibrinolytic response to elective surgery. Br J Surg 1995; 82: 414-417.
73. Ivarsson ML, Falk P, Holmdahl L,. Response of visceral peritoneum to abdominal surgery. Br J Surg 2001; 88: 148-151. (Pubitemid 32066077)
74. Hellebrekers BWJ, Emeis JJ, Kooistra T, Trimbos JB, Moore NR, Zwinderman AH, et al., A role for the fibrinolytic system in adhesion formation. Fertil Steril 2005; 83: 122-129. (Pubitemid 40094790)
75. Hellebrekers BWJ, Trimbos-Kemper TC, Boesten L, Jansen FW, Kolkman W, Trimbos JB, et al., Preoperative predictors of postsurgical adhesion formation and the Prevention of Adhesions with Plasminogen Activator (PAPA-study): results of a clinical pilot study. Fertil Steril 2009; 91: 1204-1214.
76. Emeis JJ, van den Eijnden-Schrauwen Y, van den Hoogen CM, de Priester W, Westmuckett A, Lupu F,. An endothelial storage granule for tissue type plasminogen activator. J Cell Biol 1997; 139: 245-256. (Pubitemid 27444095)
77. Lõpez Y, Páramo JA, Valentí JR, Pardo F, Montes R, Rocha E,. Hemostatic markers in surgery: a different fibrinolytic activity may be of pathophysiological significance in orthopedic versus abdominal surgery. Int J Clin Lab Res 1997; 27: 233-237.
78. Siemens HJ, Brueckner S, Hagelberg S, Wagner T, Schmucker P,. Course of molecular hemostatic markers during and after different surgical procedures. J Clin Anesth 1999; 11: 622-629. (Pubitemid 30064441)
79. Schietroma M, Carlei F, Mownah A, Franchi L, Mazzotta C, Sozio A, et al., Changes in the blood coagulation, fibrinolysis, and cytokine profile during laparoscopic and open cholecystectomy. Surg Endosc 2004; 18: 1090-1096. (Pubitemid 38918023)
80. Diamantis T, Tsiminikakis N, Skordylaki A, Samiotaki F, Vernadakis S, Bongiorni C, et al., Alterations of hemostasis after laparoscopic and open surgery. Hematology 2007; 12: 561-570. (Pubitemid 350048068)
81. D'Angelo A, Kluft C, Verheijen JH, Rijken DC, Mozzi E, Mannucci PM,. Fibrinolytic shut-down after surgery: impairment of the balance between tissue-type plasminogen activator and its specific inhibitor. Eur J Clin Invest 1985; 15: 308-312. (Pubitemid 16185735)
82. Levi M, van der Poll T,. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med 2005; 15: 254-259. (Pubitemid 41437908)
83. Levi M, Keller TT, van Gorp E, ten Cate H,. Infection and inflammation and the coagulation system. Cardiovasc Res 2003; 60: 26-39. (Pubitemid 38373473)
84. Dobbie JW,. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12: 14-27.
85. Coles GA, Williams JD, Topley N,. Peritoneal inflammation and long-term changes in peritoneal structure and function. In Textbook of Peritoneal Dialysis, Glokal R, Khanna R, Krediet RT, Nolph KD, (eds). Kluwer Academic Publishers: Dordrecht, 2000; 565-583.
86. Haslinger B, Kleemann R, Toet KH, Kooistra T,. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-α-activated human peritoneal mesothelial cells. Kidney Int 2003; 63: 2065-2074. (Pubitemid 36605817)
87. Camerer E, Kolstø AB, Prydz H,. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1-41. (Pubitemid 26027721)
88. Boldt J, Hüttner I, Suttner S, Kumle B, Piper SN, Berchthold G,. Changes of haemostasis in patients undergoing major abdominal surgery-is there a difference between elderly and younger patients? Br J Anaesth 2001; 87: 435-440. (Pubitemid 32827480)
89. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al.,; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207.
90. Lee KW, Lip GY,. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med 2003; 163: 2368-2392. (Pubitemid 37310199)
91. Lijnen HR,. Role of fibrinolysis in obesity and thrombosis. Thromb Res 2009; 123 (Suppl 4): S46-S49.
92. Kluft C, Lansink M,. Effect of oral contraceptives on haemostasis variables. Thromb Haemost 1997; 78: 315-326. (Pubitemid 27289261)
93. Eilertsen AL, Sandvik L, Mowinckel MC, Andersen TO, Qvigstad E, Sandset PM,. Differential effects of conventional and low dose oral hormone therapy (HT), tibolone, and raloxifene on coagulation and fibrinolysis. Thromb Res 2007; 120: 371-379. (Pubitemid 46879904)
94. Sato Y, Kaji M, Metoki N, Yoshida H, Satoh K,. Coagulation-fibrinolysis abnormalities in patients receiving antiparkinsonian agents. J Neurol Sci 2003; 212: 55-58. (Pubitemid 36693965)
95. Hemelaar M, van der Mooren MJ, Rad M, Kluft C, Kenemans P,. Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: a systematic review. Fertil Steril 2008; 90: 642-672.
96. Levi M, Nieuwdorp M, van der Poll T, Stroes E,. Metabolic modulation of inflammation-induced activation of coagulation. Semin Thromb Hemost 2008; 34: 26-32. (Pubitemid 351640879)
97. Grant PJ,. Diabetes mellitus as a prothrombotic condition. J Intern Med 2007; 262: 157-172. (Pubitemid 47090159)
98. Dörr PJ, Brommer EJ, Dooijewaard G, Vemer HM,. Parameters of fibrinolysis in peritoneal fluid and plasma in different stages of the menstrual cycle. Thromb Haemost 1993; 70: 873-875. (Pubitemid 23339469)
99. Alessi MC, Juhan-Vague I,. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost 2008; 99: 995-1000. (Pubitemid 351810479)
100. Modrau II, Iversen LL, Thorlacius-Ussing OO,. Hemostatic alterations in patients with benign and malignant colorectal disease during major abdominal surgery. Thromb Res 2001; 104: 309-315. (Pubitemid 33152951)
101. Iversen LH, Okholm M, Thorlacius-Ussing O,. Pre- and postoperative state of coagulation and fibrinolysis in plasma of patients with benign and malignant colorectal disease-a preliminary study. Thromb Haemost 1996; 76: 523-528. (Pubitemid 26372005)
102. Thrall G, Lane D, Carroll D, Lip GY,. A systematic review of the effects of acute psychological stress and physical activity on haemorheology, coagulation, fibrinolysis and platelet reactivity: implications for the pathogenesis of acute coronary syndromes. Thromb Res 2007; 120: 819-847. (Pubitemid 47418227)
103. Hellgren M,. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003; 29: 125-130.
104. Rosenfeld BA, Beattie C, Christopherson R, Norris EJ, Frank SM, Breslow MJ, et al., The effects of different anesthetic regimens on fibrinolysis and the development of postoperative arterial thrombosis. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology 1993; 79: 435-443. (Pubitemid 23263686)
105. Levy JH,. Massive transfusion coagulopathy. Semin Hematol 2006; 43 (Suppl 1): S59-S63. (Pubitemid 43150501)
106. Lundorff P, Hahlin M, Källfelt B, Thorburn J, Lindblom B,. Adhesion formation after laparoscopic surgery in tubal pregnancy: a randomized trial versus laparotomy. Fertil Steril 1991; 55: 911-915.
107. Boys F,. The profylaxis of peritoneal adhesions. A review of the literature. Surgery 1942; 11: 118-168.
108. Hellebrekers BWJ, Trimbos-Kemper GCM, Trimbos JB, Emeis JJ, Kooistra T,. Use of fibrinolytic agents in the prevention of postsurgical adhesion formation. Fertil Steril 2000; 74: 203-212. (Pubitemid 30604178)
109. Prasad K,. C-reactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 2006; 24: 33-50. (Pubitemid 46722293)
110. Mora S, Ridker PM,. Justification for the use of statins in primary prevention: an intervention trial evaluating rosuvastatin (JUPITER)-can C-reactive protein be used to target statin therapy in primary prevention? Am J Cardiol 2006; 97: 33A-41A. (Pubitemid 43139718)
111. Schonbeck U, Libby P,. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as antiinflammatory agents? Circulation 2004; 109 (Suppl 1): II18-II26. (Pubitemid 38724152)
112. Krysiak R, Okopień B, Herman ZS,. Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolytic processes. Drugs 2003; 63: 1821-1854. (Pubitemid 37083030)
113. Haslinger B, Goedde MF, Toet KH, Kooistra T,. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering. Kidney Int 2002; 62: 1611-1619. (Pubitemid 35286268)
114. Aarons CB, Cohen PA, Gower A, Reed KL, Leeman SE, Stucchi AF, et al., Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg 2007; 245: 176-184. (Pubitemid 46148475)
115. Kucuk HF, Kaptanoglu L, Kurt N, Uzun H, Eser M, Bingul S, et al., The role of simvastatin on postoperative peritoneal adhesion formation in an animal model. Eur Surg Res 2007; 39: 98-102. (Pubitemid 46514791)
116. Yilmaz B, Aksakal O, Gungor T, Sirvan L, Sut N, Kelekci S, et al., Metformin and atorvastatin reduce adhesion formation in a rat uterine horn model. Reprod Biomed Online 2009; 18: 436-442.